U.S. federal trademark · Serial No. 98165301
Radiopharmaceutical product for the treatment of cancer; radiopharmaceutical compounds for the treatment of neuroendocrine tumors; pharmaceutical preparations for the treatment of somatostatin receptor-positive neuroendocrine tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.